Ireland-based biopharmaceutical company Jazz Pharmaceuticals plc (JAZZ) has agreed to acquire UK-based GW Pharmaceuticals plc (GWPH,GWP.L) for a total consideration of $7.2 billion, or $6.7 billion net of GW cash, the two companies said Wednesday.
Jazz Pharma noted that the acquisition of GW Pharma will expand its growing neuroscience business by adding Epidiolex, a global, high-growth childhood-onset epilepsy franchise with near-term blockbuster potential. Epidiolex is the first and only FDA-approved prescription cannabidiol medicine.
For comments and feedback contact: editorial@rttnews.com
Business News
June 12, 2026 17:14 ET Major central bank action was the focus this week in economic news. The European Central Bank became the first major central bank to move in response to the rising inflationary pressures in the backdrop of the conflict in the Middle East. In North America, the U.S. inflation and trade data as well as Canada’s central bank decision gained attention. The Chinese trade data was the main news in Asia.